Although rare, post-transplant CML warrants high clinical suspicion, routine blood count surveillance, and reflex BCR::ABL1 testing of unexplained leukocytosis. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.